Outcomes of second-line therapies in patients with metastatic de novo small cell prostate cancer (SCPC) and treatment-emergent neuroendocrine prostate cancer (tNEPC).

被引：0
|
作者：
Eule, Corbin
Hu, Junxiao
Al-Saadi, Sulaiman
Collier, Katharine
Boland, Patrick James
Mckay, Rana R.
Narayan, Vivek
Bosse, Dominick
Mortazavi, Amir
Rose, Tracy L.
Lam, Elaine T.
机构：
[1] Univ Colorado, Canc Ctr, Aurora, CO USA
[2] Univ Colorado, Canc Ctr, Biostat Core, Aurora, CO USA
[3] Ottawa Hosp, Canc Ctr, Ottawa, ON, Canada
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[6] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA
[7] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17022
引用
收藏
页码：E17022 / E17022
页数：1
相关论文
共 50 条
  • [31] Second-line treatment of patients with metastatic colorectal cancer
    Rougier, P
    Lepere, C
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S48 - S54
  • [32] Treatment-emergent small-cell neuroendocrine prostate carcinoma: a case report and review of therapeutic challenges
    Huern, Seo Yiie
    Wee, Ooi Yeon
    Sundrarajoo, Theinesh
    Alagappan, Kumarappan
    Manoharan, Devindran
    Lechmiannandan, Sivaneswaran
    BJU INTERNATIONAL, 2024, 134 : 7 - 7
  • [33] Current status of second-line treatment and novel therapies for small cell lung cancer
    Tiseo, Marcello
    Ardizzoni, Andrea
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : 764 - 772
  • [34] Second-line treatment of small cell lung cancer
    Schmittel, A.
    Sebastian, M.
    Niederle, N.
    ONKOLOGE, 2013, 19 (11): : 940 - +
  • [35] Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review
    Colloca, Giuseppe
    Venturino, Antonella
    Checcaglini, Franco
    MEDICAL ONCOLOGY, 2012, 29 (02) : 776 - 785
  • [36] Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review
    Giuseppe Colloca
    Antonella Venturino
    Franco Checcaglini
    Medical Oncology, 2012, 29 : 776 - 785
  • [37] Patterns of second-line chemotherapy for metastatic prostate cancer in the United States.
    Wang, Hongwei
    Liao, Laura
    Obi-Tabot, Eliot
    Sands, Robert
    Rose, Mathieu
    Zhang, Quanwu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [38] Treatment-induced neuroendocrine prostate cancer and de novo neuroendocrine prostate cancer: Identification, prognosis and survival, genetic and epigenetic factors
    Wishahi, Mohamed
    WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (13)
  • [39] Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer
    Cattrini, Carlo
    Soldato, Davide
    Rubagotti, Alessandra
    Zinoli, Linda
    Zanardi, Elisa
    Barboro, Paola
    Messina, Carlo
    Castro, Elena
    Olmos, David
    Boccardo, Francesco
    CANCERS, 2020, 12 (10) : 1 - 11
  • [40] The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer
    Mather, Rebecca L.
    Andrews, Henry
    Pandha, Hardev
    Jachetti, Elena
    Micallef, Jake
    Wang, Yuzhuo
    Crea, Francesco
    FUTURE ONCOLOGY, 2020, 16 (06) : 147 - 150
12345